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Abstract
Background: South-Asian’s are predisposed to early onset type 2 diabetes (T2DM). The prevalence of cardio-metabolic risk-
factors in young Sri-Lankans is unknown.
Methodology/Principal Findings: To determine by questionnaire and anthropometry the prevalence of first degree family
history (FH) of T2DM, physical inactivity, raised waist circumference (WC) and raised body mass index (BMI) in a
representative healthy urban population selected by cluster sampling. Those with $2 risk-factors were evaluated for
metabolic syndrome (MS) and recruited for an intervention trial. Of 23,296 participants screened, 22,507 (53% Female) were
eligible [8,497 aged 10–14 yrs, 4,763 aged 15–19 yrs and 9,247 aged 20–40 yrs]. 51% had none of the 4 risk-factors, 26% 1
risk-factor and 23% (5,163) $2 risk-factors of whom 4,532 were assessed for MS. Raised BMI was noted in 19.7% aged 10–
14 yrs, 15.3% between 15–19 yrs, and between 20–40 yrs, 27.4% of males vs. 21.8% of females p,0.001. Prevalence of
raised WC was greater in females for each age group: 42.7% vs. 32.1%; 28.1% vs. 16.1%; 34.5% vs. 25.7% (p,0.05 for all) as
was physical inactivity: 39.9% vs. 14.5%; 51.7% vs. 20.0%; 62.7% vs. 41.3% which rose in both sexes with age (p,0.05 for all).
FH of T2DM was present in 26.2%. In 4532 (50%,16 yrs) with $2 risk-factors, impaired fasting glycaemia/impaired glucose
tolerance (pre-diabetes) prevalence was 16%. MS was more prevalent in males [10–16 yrs (13.0% vs. 8.8%), 16–40 yrs (29.5%
vs. 20.0%) p,0.001 for both].
Conclusions/Significance: There is a high prevalence of modifiable cardio-metabolic risk-factors in young urban Sri-Lankans
with significant gender differences. A primary prevention intervention trial is ongoing in this cohort. Clinical Trial
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Introduction
Type 2 Diabetes Mellitus (T2DM) and associated cardiovascu-
lar complications pose a major health care burden worldwide.
Recent data indicates that South Asia is one of the major sites of
this epidemic of T2DM with a projected 72% increase in the
number of subjects with T2DM in the next 20 years [1]. In parallel
there is an epidemic of pre-diabetes [impaired glucose tolerance
(IGT) and impaired fasting glycaemia (IFG)] with prevalence rates
between 10–15% reported in South Asian adult populations [1].
T2DM and IGT are associated with a significantly increased risk
of cardiovascular disease (CVD) with South Asian’s particularly
predisposed to early onset of T2DM and CVD, with almost a third
of future T2DM cases predicted to be in those below 45 years [1].
Both CVD and T2DM may share a common pathogenesis and
indeed retain many common risk factors/features [1,2].
Sri-Lanka is a middle income country in Asia with a population
of approximately 20 million. Nearly 40% of Sri Lankans are aged
below 40 years and 25% are aged below 18 years [3]. There has
been a rapid urbanisation in recent decades with an estimated
30% of the population now living in urban areas [3]. The most
recent national study in subjects aged over 20 years indicated a
population prevalence of dysglycaemia (defined as T2DM or IGT
or IFG) of 20% which rose to 30% in urban areas [4]. Physical
inactivity, raised body mass index (BMI) and central obesity along
with urban living were strongly associated with the increased risk
of dysglycaemia. In this study only 35% (n=1530) of subjects were
below 40 years of age of whom less 300 were urban dwelling and
no subjects aged below 20 years were studied [4].
The DIABRISK-SL research programme is aimed to imple-
ment and evaluate a primary prevention intervention to reduce the
incidence of T2DM and predictors of cardio-metabolic disease in
young at-risk subjects. We employed a ‘high-risk’ strategy by
selecting individuals who were at increased risk of T2DM or CVD.
In view of the relatively young age of onset of these conditions in
the Sri Lankan population, the project aimed to recruit males and
females who were between 10–40 years old. The purpose of this
paper is to report on the sampling strategy and screening
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available concerning cardio-metabolic risk in youthful South Asian
populations, this report also aims to describe the frequency of
cardio-metabolic risk factors in the screened population, as well as
in the high risk sample.
Methods
Ethics statement
Ethical approval from the Sri-Lanka Medical Association
Ethical Review Committee and permission from the Ministry of
Education was obtained for this study which was conducted under
the Good Clinical Practice principles and guidelines and according
to the principles expressed in the Declaration of Helsinki for
clinical research (Text S1). All study participants gave written
informed consent.
DIABRISK-SL [Clinical Trial Registration Number SLCTR/
2008/World Health Organization (WHO) international clinical
trial registry platform] is an on-going open randomized controlled
parallel group clinical trial evaluating the effect of intensive
(3-monthly) vs. less-intensive (annual; control group) lifestyle
modification advice on a primary composite cardio-metabolic
end point (new onset T2DM and IGT, hypertension, albuminuria,
CVD and renal events) in ‘at risk’ urban subjects aged 10–40
years. This manuscript presents the results from stage one
(screening) and stage two (baseline evaluation of subjects ‘at
high-risk’ selected for intervention) of the study.
Subjects
Stage one involved screening of a population representative of
the general population of Colombo District, the most populous
urban district in Sri-Lanka, aged between 10 to 40 years to identify
the prevalence of four risk-factors namely first degree family
history (FH) of T2DM, physical inactivity, raised BMI and raised
waist circumference. Stage 2 involved subjects with two or more
risk- factors being invited to attend the National Diabetes Centre
for baseline evaluation and characterization by clinical and
laboratory testing prior to randomization into the two trial arms.
The sampling strategy was designed to provide a sample that
was representative of the age and sex distribution of the general
population aged between 10–40 years in the Colombo district [3].
A list of schools, workplaces, universities, civil and community
organizations/societies within a 30 km radius of the National
Diabetes Centre in Colombo Sri Lanka that was representative of
the organizations and population aged between 10 to 40 years
obtained from the most recent national census results for the
district of Colombo was made. This list comprised of 65
organizations and each of these organizations were individually
approached and eligible participants were invited to take part in
the screening study. Community organizations included societies
and communities which included subjects who were unemployed,
school drop outs, and housewives within the age group specified.
The age and sex distribution of the screened population was
regularly compared with the distribution of the reference
population from the census data to ensure that the screened
population was representative of the distribution of the general
urban population aged between 10 and 40 years in the Colombo
district. More than 95% of subjects and institutions approached
agreed to participate. An open invitation via leaflet and posters for
any member (within the age group criteria of the study) of these
institutions was made and all those who volunteered and fulfilled
the inclusion criteria were accepted into the study.
Screening was conducted by a research team of between 6–12
personnel from the National Diabetes Centre who are all trained
in healthcare research methodology and practice. These staff were
supervised and supported by one medical doctor and one clinical
study coordinator.
Stage 1 took place on site at the respective institutions/sites and
stage 2 was done at National Diabetes Centre in Colombo. The
screening survey took place between 1
st January 2008 and 30
th
June 2009. Subjects with a known history of T2DM, CVD,
hypertension or diabetes and pregnant women were excluded
from the initial sample. Subjects on lipid lowering drugs or anti-
diabetic or anti-hypertensive drugs were also excluded. A
screening questionnaire (Text S2) was used to determine first
degree FH of T2DM and the physical activity of the individual
participants. Further information regarding socio-demographic
factors was also collected.
Procedures
The screening study aimed to identify four risk-factors: physical
inactivity (,30 minutes continuous exercise for ,3 days/week),
raised WC (central obesity) defined as WC in subjects between 10–
17 yrs $91
th percentile, 18–40 yrs: females $80 cm and males
$90 cm, first degree FH of T2DM and raised BMI defined in
subjects aged 10–18 yrs of a BMI value greater than internation-
ally standardized age and sex specific percentile cutoffs and
between 18–40 yrs as BMI $23 kg/m
2 [5,6,7]. These four factors
were chosen on the basis of a pilot study that identified these risk-
factors as being highly prevalent in 1239 subjects aged below 40
years with a new diagnosis of T2DM who attended the National
Diabetes Centre in Colombo between 2005–2007 and are
supported by recent data from comparable South Asian and Sri
Lankan populations [1,4,7,8].
Following the screening questionnaire anthropometric mea-
surements of WC, height and weight were performed in all
subjects. Height was measured using a portable stadiometer (Seca,
Rumily, France) calibrated weekly and taken to the closest 0.1 cm.
Weight was measured with an electronic weighing scale (Seca,
Rumily, France), calibrated weekly, without footwear in light
clothing to the nearest 100 g. BMI was calculated as weight in
kilograms divided by height squared in meters. WC taken using a
graduated measuring tape (Seca, Rumily, France), calibrated
weekly, with a locking device to the nearest 0.1 cm. WC was taken
at the mid- point between the iliac crest and the last rib in
expiration. WHO approved growth charts for males and female
children were used [9].
In stage 2 subjects with two or more risk factors attended the
National Diabetes Centre where biochemical testing and a
standard 2 hour 75 g oral glucose tolerance test (OGTT) was
performed in adults and glucose solution 1.75 g/kg body weight,
to a maximal dose of 75 g was given to those below 16 years
following a 12 hour fast as per WHO guidelines [10]. Plasma
Glucose, total cholesterol, high density lipoprotein (HDL), low
density lipoprotein (LDL),triglycerides and serum creatinine were
measured by enzymatic colorimetry (Vitros MS 250, Ortho
Clinical Diagnostics, Johnson and Johnson, Rochester USA).
Fasting plasma insulin was measured using radioimmunoassay
(Immulite, Siemens, Surrey, UK), which has a sensitivity of 4 mU/
ml (,24 pmol/l) and intra and interassay coefficients of variation
,8%. Insulin resistance was calculated using the homeostasis
model assessment of insulin resistance (HOMA-IR) [11]. Urine
albumin to creatinine ratio was measured by immunoturbidimetry
(Vitros 5,1 FS Chemistry System, Ortho-Clinical Diagnostics,
Johnson and Johnson, Hampshire, United Kingdom) from an
early morning urine sample. Blood pressure was measured by
automatic oscillometry from the non-dominant arm after 5 min-
Cardio-Metabolic Risk in Young Urban South Asians
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31309utes rest with the mean of two measurements recorded (Riester Ri-
Champion Riester, Jungingen, Germany).
New cases of T2DM were diagnosed according to the WHO
and American Diabetes Association criteria [10,12]. IGT was
defined as fasting glucose ,126 mg/dl (7.0 mmol/l) and 2-h
glucose 140–200 mg/dL (7.8–11.0 mmol/l) and IFG as fasting
plasma glucose 100–125.9 mg/dL (5.6–7 mmol/l) [12]. New cases
of hypertension were defined as mean brachial blood pressure
$140/90 mmHg in adults and those below 18 years hypertension
was defined as blood pressure that is, on repeated measurement, at
the 95th percentile or greater adjusted for age, height, and sex as
per Joint National Committee guidelines on Prevention, Detec-
tion, Evaluation, and the Treatment of High Blood Pressure (JNC-
7) [13].
Metabolic syndrome, was defined by International Diabetes
Federation (IDF) criteria for children, adolescents and adults
[6,14]. These are for subjects $16 years the presence of central
obesity plus any two of the following; raised triglycerides levels
$150 mg/dl (1.7 mmol/l), reduced HDL-cholesterol ,40 mg/dL
(1.03 mmol/l) in males and ,50 mg/dL (1.29 mmol/l) in females,
raised blood pressure [systolic blood pressure (SBP) $130 mmHg
or diastolic blood pressure (DBP) $85 mmHg] and raised fasting
glucose $100 mg/dL (5.6 mmol/l) is required [13]. The IDF
criteria for those between 10 to 16 years are a central obesity plus
the presence of any two or more of following; raised triglycerides,
reduced HDL-cholesterol, raised SBP or DBP mmHg and raised
fasting blood glucose [6].
The team involved in data collection followed good clinical
research practice guidelines. All data entry was double checked by
two researchers and entered into a dedicated computer soft ware
data base system which was maintained and scrutinized by an in
house IT consultant. The research team have monthly internal
reviews of the data base and data entry processes/procedures to
ensure that good practice is followed for data entry/data
management. These process and procedures has been indepen-
dently reviewed and approved by the independent advisory and
data monitoring committee for the study and reviewers from the
IDF Bridges grant committee.
Statistical Analysis
Data values were coded to missing if they were more than four
standard deviations from the sample mean. The number of such
values was noted in 30 subjects. Descriptive statistics were used for
the analysis of demographic and clinical features of the cohort.
Analyses were performed using STATA software version 11 (Stata
Corp, College Station, TX, USA). The cluster sampling design
gave rise to substantial intraclass correlation coefficients. The ‘svy’
commands in Stata were utilized to obtain standard errors through
Taylor-linearized variance estimation with organization as the
primary sampling unit. Descriptive statistics were used for the
analysis of demographic and clinical features of the cohort. Data
are given as mean (95% confidence intervals) unless otherwise
stated. Group comparisons were made using median test or chi
squared test as relevant. All P values are presented with adjustment
for multiple comparisons. Analyses were performed using STATA
software version 10 (Stata Corp, College Station, TX, USA).
Results
The sample was drawn from 65 organizations which included
38 workplaces, 15 schools, five universities and 7 community
organizations. There were 23,296 subjects screened for the study.
There were 393 subjects excluded because they were aged less
than 10 years or greater than 40 years and 396 excluded due to
being on treatment for and/or having a known diagnosis of
T2DM, CVD, hypertension or raised cholesterol levels, kidney
disease and pregnancy.
After excluding these ineligible subjects there were 22,507
participants (47% males, 53% female) evaluated in stage one of the
study. Of the 22,507 eligible subjects 8,497 (males 44.8%) were
aged 10 to 14 years, 4,763 (males 41.4%) aged 15 to 19 years and
9,247 (males 51.3%) aged 20 to 40 years. The clinical and
anthropometric characteristics of the 22,507 subjects are presented
in Table 1. The overall prevalence of a raised BMI between 10–14
and 15–19 yrs was 19.7% and 15.3% respectively with no
significant differences between males and females. Between 20–
40 years 27.4% of males and 21.8% of females were overweight
(p,0.001 males vs. females). In contrast there was no significant
gender differences in the prevalence of obesity in subjects aged
between 20–40 years and below 14 years. Between 15–19 years
the prevalence of obesity was significantly higher in males
although the overall number of subjects were smaller than in the
other age ranges (Table 1). Prevalence of central obesity was
significantly greater in females for each age group (Table 1).
Similarly physical inactivity was significantly greater in females
compared to males for each age group (Table 1).
Furthermore physical inactivity significantly increased with age
for both males and females (p,0.01). A first degree FH of T2DM
was documented in 26.5% of all subjects studied. Of interest a FH
of T2DM was significantly more prevalent in females compared to
males across all age groups (p,0.01).
Of the eligible subjects 11,456 (51%) had none of the four risk
factors, 5,888 (26%) one risk factor and 5,163 (23%) two or more
risk factors. Two or more risk factors were noted in 24.0% of
subjects aged 10–14 yrs, 16.9% between 15–19 yrs and 25.0% in
those aged 20–40 yrs.
Of the 5,163 subjects with two or more risk factors 4532 subjects
(50% below 16 years) were further evaluated in stage 2 and
entered the prospective clinical trial. Those subjects eligible for
participation in the trial following screening but who did not wish
to take part or failed attend for further evaluation (n=631) did not
differ from those entered into the clinical trial in any baseline
characteristics (data not shown).
The clinical and biochemical baseline characteristics of the
4,532 selected subjects according to age groups and gender are
shown in Table 2. In the whole cohort central obesity was detected
in 70.6% of subjects and a raised BMI in 51.1%.
In those below 14 years, 29 (4.7%) males and 31 (3.9%) females
were diagnosed with IFG. In those between 15 to 19 years, 24
males (9.2%) and 17 females (3.0%) had IFG. IFG was diagnosed
in 190 (15.1%) males and 90 females (7.9%) between 20–40 years.
Prevalence of IGT was identical in males and females below 14
years (3.9% for both 31 females and 24 males), and was similar
between males and females aged between 14–19 years [25 (4.4%)
females and 11 (4.2%) males]. Between 20–40 years, 148 males
(11.7%) and 123 (10.8%) females had IGT.
Overall prevalence of IFG and IGT was 16%. T2DM was
newly diagnosed in 106 subjects (59 males and 47 females) with 3
cases (all females) in subjects below 15 years and 6 cases (5 females,
1 male) in subjects between 15–19 years of age and the remainder
in those between 20–40 years (58 males, 39 females). Fasting
insulin levels, HOMA-IR were not significantly different between
males and females in the reported age ranges (Table 2). Urine
ACR results confirmed well known gender differences and ACR
did not increase significantly with age.
As the age specific IDF criteria to diagnose metabolic syndrome
use 16 years as a cut off, the 4532 selected subjects were split in to
two age groups (above and below 16 years) for further analyses.
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significantly greater in males vs. females (88.5% vs. 79.2%
p,0.001). This trend was reversed in those over 16 years with a
greater prevalence of central obesity in females (67.4% vs. 59.9%
p,0.001). Elevated triglycerides were noted in 12.2% of subjects
below 16 years and 24.5% above 16 years. Males had a greater
prevalence of elevated triglycerides as compared to females in
subjects below 16 years (15.0% vs. 10.0% p=0.002) and above 16
years (36.6% vs. 12.8% p,0.001). Low HDL levels were detected
in 28.3% of those below 16 years and in 58.9% of subjects over 16
years of age. Below 16 years males had a significantly greater
prevalence of low HDL levels (32.8% vs. 25.2% p=0.001) and
over 16 years this trend was reversed with a greater prevalence in
females (50.8% of males vs. 66.7% of females p,0.001). Raised
Table 1. Demographic and anthropometric characteristics of 22,507 subjects representative of the urban population of Colombo
District aged between 10–40 years.
Characteristic Age 10–14 (n=8,497) Age 15–19 (n=4,763) Age 20–40 (n=9,247)
Gender Males (n=3,802) Females (n=4,695) Males (n=1,974) Females (n=2,789) Males (n=4,741) Females (n=4,506)
Height (cm) 150.6 (149.0 to 152.1) 150.2 (148.5 to 152.0) 168.6 (167.2 to 168.5) 156.8 (156.3 to 157.3) 167.9 (167.2 to 168.5) 155.2 (154.6 to 155.8)
Weight (kg) 42.0 (40.2–43.7) 43.0 (41.0 to 45.0) 57.8 (55.9 to 59.8) 50.4 (49.5 to 51.2) 64.4 (62.7 to 66.2) 53.1 (51.1 to 55.1)
BMI (kg/m
2) 18.2 (17.7 to 18.7) 18.8 (18.3 to 19.3) 20.3 (19.8 to 20.7) 20.4 (20.1 to 20.8) 22.8 (22.3 to 23.4) 22.0 (21.3 to 22.7)
Waist (cm) 67.9 (66.3 to 69.4) 66.9 65.2 to 68.5) 75.5 (73.7 to 77.3) 70.6 (69.3 to 72.0) 83.0 (81.4 to 84.5) 75.4 (72.8 to 78.1)
FH of T2DM 21.0 (18.8 to 23.2) 23.8 (20.9 to 22.7)
b 26.1 (22.4 to 29.8) 30.8 (29.3 to 32.3)
b 27.0 (22.6 to 31.3) 29.9 (25.2 to 34.5)
b
Physical inactivity 14.5 (12.6 to 16.3)
c 39.9 (29.5 to 50.1)
bc 20.0 (16.2 to 23.7)
c 51.7 (46.4 to 56.9)
bc 41.3 (34.8 to 47.6)
c 62.7 (51.7 to 73.7)
bc
Overweight 19.0 (15.2 to 22.8) 20.2 (17.2 to 23.2) 15.5 (12.2 to 18.7) 15.2 (12.3 to 18.2) 27.4 (22.2 to 32.6)
a 21.8 (16.3 to 27.4)
Obese 4.7 (3.2 to 6.1) 4.3 (3.1 to 5.6) 4.0 (2.8 to 5.1) 2.7 (1.9 to 3.4) 3.8 (2.6 to 5.0) 4.2 (2.0 to 6.3)
Central obesity 32.1 (27.0 to 37.3) 42.7 (37.0 to 48.4)
b 16.1 (9.7 to 22.4)
b 28.1 (22.0 to 34.2)
b 25.7 (20.2 to 31.1)
b 34.5 (25.2 to 43.8)
b
amales vs.females p,0.001.
bfemales vs.males p,0.05.
cAge 10–14 years vs. 15–19 yrs vs 20–40 yrs p,0.05 for all.
Data are reported as means or proportions (%) with 95% confidence intervals corrected for cluster sampling.
Abbreviations: BMI, body mass index; FH, first degree family history; T2DM, type 2 diabetes mellitus.
doi:10.1371/journal.pone.0031309.t001
Table 2. Baseline clinical and biochemical characteristics of 4532 subjects aged between 10–40 years with $2 cardio-metabolic
risk factors selected for participation in the randomized controlled trial.
Characteristic
Age 10–14
(n=1,382)
Age 15–19
(n=822)
Age 20–40
(n=2,328)
Gender Males (n=596) Females (n=786) Males (n=260) Females (n=562) Males (n=1,212)
Females
(n=1,116)
BMI (kg/m
2) 22.8 (22.2 to 23.4) 21.8 (21.0 to 22.6) 25.1 (24.5 to 25.7) 23.3 (23.0 to 23.7) 25.7 (25.4 to 26.0) 24.8 (24.2 to 25.3)
Waist circumference (cm) 82.5 (80.6 to 84.4) 76.0 (73.6 to 78.4) 89.5 (87.7 to 91.3) 79.7 (78.6 to 80.8) 91.6 (90.6 to 92.7) 84.8 (83.2 to 86.3)
SBP (mmHg) 108 (106 to 110) 108 (107 to 109) 119.1 (118 to 120) 111 (109 to 113) 123 (122 to 124) 113 (112 to 114)
DBP (mmHg) 66 (65 to 67) 67 (66 to 68) 71 (70 to 73) 69 (68 to 71) 77 (77 to 78) 72 (71 to 73)
FPG (mg/dL)) 90 (89 to 90) 88 (87 to 89) 90 (89 to 90) 88 (87 to 89) 94 (92 to 95) 90 (88 to 93)
2 hr OGTT PG (mg/dL) 103 (102 to 105) 105 (104 to 108) 102 (99 to 105) 106 (103 to 108) 113 (109 to 117) 115 (109 to 121)
Triglycerides (mg/dL) 107 (104 to 110) 97 (90 to 105) 106 (97 to 115) 88 (83 to 92) 147 (141 to 152) 101 (98 to 105)
Total cholesterol (mg/dL) 181 (178 to 183) 179 (177 to 181) 174 (172 to 177) 182 (179 to 185) 210 (208 to 213) 196 (195 to 198)
LDL cholesterol (mg/dL) 114 (111 to 116) 113 (111 to 114) 111 (110 to 113) 116 (113 to 119) 140 (138 to 143) 130 (128 to 131)
HDL cholesterol (mg/dL) 45 (44 to 46) 47 (45 to 48) 42 (40 to 43) 48 (47 to 49) 40 (39 to 41) 46 (45 to 47)
Fasting insulin (mIU/L) 14.2 (12.4 to 16.0) 14.0 (12.6 to 15.5) 14.4 (13.1 to 15.8) 12.9 (12.2 to 13.5) 11.1 (10.3 to 11.8) 10.1 (9.8 to 10.4)
HOMA-IR % 3.1 (2.8 to 3.5) 3.1 (2.8 to 3.4) 3.2 (2.9 to 3.5) 2.8 (2.7 to 3.0) 2.6 (2.4 to 2.8) 2.3 (2.2 to 2.4)
Serum creatinine (mg/dL) 0.59 (0.57 to 0.61) 0.56 (0.55 to 0.57) 0.80
(0.77 to 0.82)
0.64 (0.63 to 0.65) 0.96 (0.94 to 0.97) 0.69 (0.68 to 0.70)
Urine ACR (mg/g) 6.0 (5.1 to 6.9) 10.8
(6.7 to 15.0)
8.4 (3.9 to 12.8) 8.9 (5.9 to 11.9) 6.0 (4.0 to 8.1) 8.7 (5.7 to 11.7)
Data are reported as means with 95% confidence intervals corrected for cluster sampling.
Abbreviations: BMI, body mass index; SBP, Systolic blood pressure; DBP Diastolic blood pressure; FPG, Fasting plasma glucose; PG, plasma glucose; LDL, low density
lipoprotein; HDL, high density lipoprotein; HOMA-IR, Homeostasis model assessment for insulin resistance; ACR, albumin to creatinine ratio.
doi:10.1371/journal.pone.0031309.t002
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in 23.1% of subjects above 16 years of age. There were no
significant gender differences in the prevalence of hypertension in
those below 16 years (7.2% of males vs. 6.2% of females). Above
16 years males had a significantly greater prevalence of
hypertension (33.2% vs. 13.4% p,0.001).
In subjects below 16 years of age the prevalence of raised fasting
plasma glucose was similar between males and females (5.9% of
males vs. 4.2% of females), however over 16 years males had a
greater prevalence (17.2% of males vs. 8.5% of females p,0.001).
Metabolic syndrome was diagnosed in 13.0% of males and 8.8%
of females below 16 years (p=0.005) and in 29.5% of males and
20.0% of females over 16 years (p,0.001).
Discussion
This is the first large population based study to determine the
prevalence of T2DM, pre-diabetes (IGT and IFG), and cardio-
metabolic risk factors in young urban Sri-Lankans. Our results
show a high prevalence of modifiable risk factors for cardio-
metabolic disease in subjects aged between 10–40 years.
Importantly these risk factors are present early with significant
gender and age differences. We also aimed to develop a method
for identifying a sample at increased risk of diabetes and
cardiovascular disease for a randomized controlled trial of a new
intervention strategy. The results show that a simple screening
strategy based on self-reported physical inactivity, family history of
diabetes in first degree relatives, as well as obesity and increased
waist circumference provides an efficient method for identifying a
sample with a very high frequency of features characteristic of the
metabolic syndrome. Recently the entity of the metabolic
syndrome per se and its value as syndrome has been questioned
[15]. What is relevant is that the metabolic syndrome does identify
subjects at higher cardio-metabolic risk and that the individual risk
factors for CVD and T2DM cluster and are inter-related [14–16].
Metabolic syndrome is a practical tool in focusing public health
attention and in its purest form, as we have reported with the
exclusion of those with known T2DM or CVD and with a detailed
description of the individual and related risk components, it is a
pre-morbid condition that may be useful in developing country
specific public health intervention strategies [14,15].
In this study we report the early determinants of cardio-
metabolic risk in a young at risk population and this work will
helps us further understand underlying key mechanisms such as
central obesity and insulin resistance, which underlie the clustering
of cardio-metabolic risk factors [14].
Our results from the screening of a sample representative of the
general population of Colombo district, indicate that in children
aged between 10–14 years two or more risk factors for cardio-
metabolic disease were noted in 24% which is nearly equivalent to
the prevalence in those .20 years. This has not been reported
previously in Sri Lanka or South Asia and is of great public health
concern. The exact mechanisms/explanations for this high
prevalence remain unclear however we could speculate that
recent trends in less school time exercise/sports and increased
exposure of children to unhealthy diets may underlie these results.
In children aged between 10 to 14 years the prevalence of central
obesity was 38% and nearly 20% were overweight with a
significantly greater prevalence of central obesity in females. In
subjects between 15–19 years the prevalence of central obesity was
23.1% with a greater female preponderance. Our data are similar
to that reported in 2640 subjects aged between 12–19 years from
Chennai, South India where prevalence of overweight subjects was
15% and central obesity defined by a lower waist circumference
cut-off (.75th percentile) was noted 23.7% subjects [16]. The
authors of this study however did not report significant gender
differences in their results. A recent study from the city of Karachi
in Pakistan reported an overall prevalence of overweight and
obesity of 7% in boys and 11% in girls aged 13–14 years which the
authors reported is a two fold rise over 10 years [17]. This
dramatic rise was associated with a decline in physical activity and
this data as well our results mirrors global trends of rising
childhood obesity. The prevalence of obesity we report in those
below 14 years is broadly similar to that reported from much
smaller studies in Sri-Lanka, however in contrast to previous
reports work we did not observe a significantly higher prevalence
in males [18]. Importantly being overweight in childhood is an
antecedent of adult obesity and is associated with heightened risk
of overt cardio-metabolic disease. Therefore, it is vital to estimate
the prevalence of overweight/obese children as it is a step towards
identifying high risk groups to evolve preventive strategies.
Recent data from adults subjects from Pakistan and Sri Lanka
indicate that the factors independently and significantly associated
with being overweight and obesity include older age, being female,
urban residence, being literate, and having a high economic status
[19,20].
The percentage prevalence of overweight adults (defined as
BMI$23 kg/m
2) and obese (defined as $BMI 27.5 kg/m
2) urban
Sri-Lankans in a recent national survey was 32.7% and 18.5%
respectively with females noted to have a greater prevalence in
both categories compared to males [19]. Our data from a younger
population indicates similar overall prevalence of overweight
subjects but in contrast to the above results our results in those
aged between 20–40 years show a greater prevalence of being
overweight and obese in males. This may be explained by
important differences in the subjects included in the two studies.
Subjects assessed in the national survey, were significantly older
(mean age 46.3 years) than those in our study and the number of
urban subjects studied was smaller (n=1530). Our data confirms
previous results which show a higher prevalence of central obesity
in females than males aged between 20–40 years, although the
overall prevalence in urban males we report of 25.7% is higher
than the 15% prevalence described nationally [18].
Overall 26.2% of subjects had a first degree family history of
T2DM which was significantly more prevalent in females across all
age groups. The prevalence of parental history of T2DM has not
previously been studied in detail in young urban Sri-Lankans and
prospective studies are required to explain the possible significance
of the above results. A smaller study in South Asians subjects
(n=321) has previously demonstrated increased risk of glucose
intolerance, being overweight, low levels of HDL and high blood
pressure in Asian Indian adolescents with a family history of
T2DM [21] but the relative contributions, if any, of maternal or
paternal family history were not described.
In our ‘high-risk’ cohort of subjects with 2 or more risk factors
the commonest cardio-metabolic abnormality detected was low
HDL cholesterol, followed by elevated triglycerides. Similar
findings have been reported from South Asian adults and children
[16] however as the value used to define raised triglycerides in
those below 16 years in our study was higher than the values of
105 mg/dl (1.2 mmol/l) used in recent studies from South Asia [9]
and western countries [21], this is likely to be an underestimation.
Metabolic syndrome was detected in 10.4% of subjects ,16 years
and in 24.7% of those $16 years of age. Data on prevalence of
metabolic syndrome and its individual components have not
previously been reported in large numbers of young urban or
general Sri Lankan populations. Our prevalence data for
metabolic syndrome in children and young adults are higher than
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difference is likely to be due to our selection of subjects at ‘high-
risk’ in the context of screening and selection strategy to detect and
recruit several thousand ‘high-risk’ subjects for a primary
prevention trial. Interestingly the metabolic syndrome prevalence
we report of 11% is significantly lower than that of 21% reported
in a smaller number of children attending a specialist obesity clinic
in Colombo, Sri Lanka [24].
A limitation of our study was that we could not obtain full
details and data on a family history of obesity in the subjects
screened. However this study was not primarily designed to look
for these associations. Another limitation was that we could not
formally assess pubertal stages in children when they were
screened. However in the context of a population based large
screening study and local cultural attitudes this was not a feasible.
The strengths of our study is that, it is the largest urban cohort
below the age of 40 years in South Asia evaluated for cardio-
metabolic risk with more than 50% of subjects being below 16
years a group hitherto not studied in detail or in such numbers.
We provide novel information on the prevalence of key risk-factors
for cardio-metabolic disease in young subjects from the Colombo
District the most populous and urban district in Sri Lanka.
Our results which show a 16% prevalence of pre-diabetes states
(IFG/IGT) in an at risk young population raises awareness of the
growing burden of risk of T2DM and obesity in developing
countries that is of major public health and economic importance
and which requires urgent remedial actions [25,26].
A prospective study that evaluates the effect of a non-
pharmacological life style modification primary intervention
programme on a primary composite cardio-metabolic end point
and a range of cardio-metabolic secondary end-points in this
young ‘high-risk’ population of urban subjects is ongoing. This
study will also provide further information on the natural history
of cardio-metabolic risk in this unique at risk cohort.
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